WallStreetZen

NASDAQ: STAA
Staar Surgical Co Stock Forecast, Predictions & Price Target

Analyst price target for STAA

Based on 1 analysts offering 12 month price targets for Staar Surgical Co.
Min Forecast
$150.00+66.8%
Avg Forecast
$150.00+66.8%
Max Forecast
$150.00+66.8%

Should I buy or sell STAA stock?

Based on 2 analysts offering ratings for Staar Surgical Co.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

STAA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Oppenheimer
Top 38%
63
HoldInitiates Coverage On$150.00+66.80%2021-07-09
Anonymous
Canaccord Genuity
Strong BuyMaintains$150.00+66.80%2021-05-06
Benchmark
Top 34%
67
HoldDowngradesN/AN/A2021-01-19

1 of 1

Forecast return on equity

Is STAA forecast to generate an efficient return?
Company
N/A
Industry
11.59%
Market
37.5%

Forecast return on assets

Is STAA forecast to generate an efficient return on assets?
Company
N/A
Industry
6.62%

STAA earnings per share forecast

What is STAA's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$0.55+12.24%
Avg 2 year Forecast
$0.77+57.14%
Avg 3 year Forecast
$1.40+185.71%
STAA's earnings are forecast to grow at an exceptional rate of 36.5% per year
Forecast

STAA revenue forecast

What is STAA's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$230.8M+6.11%
Avg 2 year Forecast
$296.0M+36.1%
Avg 3 year Forecast
$371.5M+70.81%
STAA's revenue is forecast to grow at a rate of 19.28% per year, which is not exceptional
Forecast

STAA earnings growth forecast

How is STAA forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
36.5%
Industry
26.8%
Market
14.37%
STAA's earnings are forecast to grow faster (36.5% per year) than the US Medical Instruments & Supplies industry average (26.8%)
Forecast
STAA's earnings are forecast to grow faster (36.5% per year) than the US market average (14.37%)
Forecast
STAA's earnings are forecast to grow faster (36.5% per year) than the risk-free savings rate (1.4%)
Forecast

STAA revenue growth forecast

How is STAA forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
19.28%
Industry
6.82%
Market
10.08%
STAA's revenues are forecast to grow faster (19.28% per year) than the US Medical Instruments & Supplies industry average (6.82%)
Forecast
STAA's revenues are forecast to grow faster (19.28% per year) than the US market average (10.08%)
Forecast

Staar Surgical Stock Forecast FAQ

Is Staar Surgical Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: STAA) stock is to Hold STAA stock.

Out of 2 analysts, 0 (0%) are recommending STAA as a Strong Buy, 0 (0%) are recommending STAA as a Buy, 2 (100%) are recommending STAA as a Hold, 0 (0%) are recommending STAA as a Sell, and 0 (0%) are recommending STAA as a Strong Sell.

What is STAA's earnings growth forecast for 2021-2023?

(NASDAQ: STAA) Staar Surgical's forecast annual earnings growth rate of 36.5% is forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 26.8%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Staar Surgical's earnings in 2021 is $22,906,000.On average, 3 Wall Street analysts forecast STAA's earnings for 2021 to be $26,180,161, with the lowest STAA earnings forecast at $25,704,158, and the highest STAA earnings forecast at $26,656,164. On average, 3 Wall Street analysts forecast STAA's earnings for 2022 to be $36,652,226, with the lowest STAA earnings forecast at $28,560,176, and the highest STAA earnings forecast at $42,840,264.

In 2023, STAA is forecast to generate $66,640,410 in earnings, with the lowest earnings forecast at $66,640,410 and the highest earnings forecast at $66,640,410.

What is STAA's revenue growth forecast for 2021-2023?

(NASDAQ: STAA) Staar Surgical's forecast annual revenue growth rate of 19.28% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.82%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Staar Surgical's revenue in 2021 is $217,469,000.On average, 3 Wall Street analysts forecast STAA's revenue for 2021 to be $10,984,529,214, with the lowest STAA revenue forecast at $10,971,867,537, and the highest STAA revenue forecast at $10,990,907,654. On average, 3 Wall Street analysts forecast STAA's revenue for 2022 to be $14,088,068,318, with the lowest STAA revenue forecast at $13,961,165,937, and the highest STAA revenue forecast at $14,284,847,929.

In 2023, STAA is forecast to generate $17,681,128,835 in revenue, with the lowest revenue forecast at $16,993,304,601 and the highest revenue forecast at $18,368,953,069.

What is STAA's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: STAA) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 6.62%.

What is STAA's Price Target?

According to 1 Wall Street analysts that have issued a 1 year STAA price target, the average STAA price target is $150.00, with the highest STAA stock price forecast at $150.00 and the lowest STAA stock price forecast at $150.00.

On average, Wall Street analysts predict that Staar Surgical's share price could stay at $150.00 by Jul 9, 2022. The average Staar Surgical stock price prediction forecasts a potential downside of N/A from the current STAA share price of $89.93.

What is STAA's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: STAA) Staar Surgical's current Earnings Per Share (EPS) is $0.49. On average, analysts forecast that STAA's EPS will be $0.55 for 2021, with the lowest EPS forecast at $0.54, and the highest EPS forecast at $0.56. On average, analysts forecast that STAA's EPS will be $0.77 for 2022, with the lowest EPS forecast at $0.60, and the highest EPS forecast at $0.90. In 2023, STAA's EPS is forecast to hit $1.40 (min: $1.40, max: $1.40).

What is STAA's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: STAA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.